Volume 30, Number 8—August 2024
Dispatch
Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017–2023
Table 1
Year | No. positive cases (%) |
p value† | ||||
---|---|---|---|---|---|---|
Total no. cases | Spring, Mar–May | Summer, Jun–Aug | Autumn, Sep–Nov | Winter, Dec–Feb | ||
2017 | 67 (43.23) | 13 (30.23) | 9 (21.43) | 21 (65.63) | 24 (63.16) | <0.001 |
2018 | 54 (58.06) | 17 (65.38) | 18 (81.82) | 4 (57.14) | 15 (39.47) | 0.010 |
2019 | 17 (38.64) | 4 (14.29) | 13 (81.25) | ND | ND | NA |
2020 | 21 (16.80) | 8 (61.54) | 7 (41.18) | 6 (12.50) | 0 | <0.001 |
2021 | 10 (13.33) | 10 (24.39) | 0 | 0 | 0 | 0.016 |
2022 | 16 (11.59) | 11 (28.21) | 2 (12.50) | 3 (4.05) | 0 | 0.002 |
2023 | 24 (17.14) | 5 (13.51) | 13 (37.14) | 3 (9.38) | 3 (8.33) | 0.008 |
Total |
209 (27.14) |
68 (29.96) |
62 (41.61) |
37 (18.14) |
42 (22.11) |
<0.001 |
p value‡ | <0.001 |
*The study period ended December 2023. NA, not applicable; ND, no data. †p value by Fisher exact test to examine the relationship between season and infection. ‡p value by Χ2 test to examine the relationship between year and infection.
Page created: June 24, 2024
Page updated: July 21, 2024
Page reviewed: July 21, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.